• Citer

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.

par van Rijswijk, R;Jeziorski, K;Wagener, Theo;Van Laethem, Jean-Luc ;Reuse, Sophie ;Baron, Benoît;Wils, Jaques;EORTC GastroIntestinal Tract Cancer Cooperative Group,
Référence European journal of cancer, 40, 14, page (2077-2081)
Publication Publié, 2004-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.
Auteur:	van Rijswijk, R; Jeziorski, K; Wagener, Theo; Van Laethem, Jean-Luc; Reuse, Sophie; Baron, Benoît; Wils, Jaques; EORTC GastroIntestinal Tract Cancer Cooperative Group,
Informations sur la publication:	European journal of cancer, 40, 14, page (2077-2081)
Statut de publication:	Publié, 2004-09
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Fluorouracil
	Leucovorin
	Pancreatic neoplasms/drug therapy
MeSH keywords:	Adult
	Aged
	Analgesics -- therapeutic use
	Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
	Antimetabolites, Antineoplastic -- therapeutic use
	Disease-Free Survival
	Dose-Response Relationship, Drug
	Female
	Fluorouracil -- administration & dosage
	Humans
	Leucovorin -- administration & dosage
	Male
	Middle Aged
	Pancreatic Neoplasms -- drug therapy
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2004.06.012
	info:pii/S0959804904005027
	info:scp/4444346409
	info:pmid/15341982